Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Meiji Seika's new orally active gpIIb/IIIa antagonist

March 20, 1997

Mitsui Toatsu reveals orally active antiplatelet agent

March 20, 1997

InTIME trial indicates nPA superior to tPA in MI

March 19, 1997

Aggrastat prevents heart attack, death and other complications in unstable angina

March 19, 1997

PGI2 agonists described by Fujisawa

March 19, 1997

Roberts' Agrylin approved by FDA

March 18, 1997

New clot buster comparable to t-PA in AMI

March 18, 1997

Pharmacodynamic effects of xemilofiban in cirrhotics

March 18, 1997

Taisho claims orally active antiplatelet agents

March 18, 1997

NM-702 enters phase II trials

March 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...